Please login to the form below

Not currently logged in
Email:
Password:

genital herpes

This page shows the latest genital herpes news and features for those working in and with pharma, biotech and healthcare.

Genital herpes vaccine candidate heads for human studies

Genital herpes vaccine candidate heads for human studies

Genital herpes is an incurable, contagious sexually-transmitted infection caused by Herpes simplex virus-2 (HSV-2) that causes a lifetime of painful outbreaks. ... Worldwide genital herpes affects a massive 400 million people, and it’s widely held that

Latest news

  • Genital herpes vaccine candidate promising in phase II Genital herpes vaccine candidate promising in phase II

    A vaccine that could free patients with genital herpes from lifelong drug treatment to control outbreaks has shown promise in a phase II trial. ... The vaccine - called GEN-003 and developed by Genocea Biosciences - is a T cell-enabled therapeutic

  • Vical's genital herpes vaccine flunks trial Vical's genital herpes vaccine flunks trial

    Vical admitted yesterday that two versions of its genital herpes vaccine failed to meet their objectives in a phase III trial, throwing the future of the programme into doubt. ... to reduce virus shedding in patients with genital herpes in the phase I/II

  • Sanofi to work with Immune Design on herpes vaccine Sanofi to work with Immune Design on herpes vaccine

    Sanofi has joined forces with US biotech Immune Design to accelerate development of the first therapeutic vaccine against genital herpes. ... Sanofi notes that genital herpes is the most common STI and affects around one in six people in the US, with

  • Medivir and Meda in Xerese renegotiation

    Medivir has renegotiated the terms of its financial arrangement with Meda for Xerese, its marketed product for herpes labialis, in North America. ... The agreement also provides Meda with the exclusive US rights to Xerese for the genital herpes indication

  • FDA cracks down on bogus STD drugs

    The two federal agencies are targeting products that make unproven claims to treat, cure, and prevent STDs including herpes, chlamydia, genital warts, HIV and AIDS. ... and proven herpes killers in a single formula"; and Viruxo, which is sold on a

More from news
Approximately 1 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics